Fierce Biotech

Endogenex nets $50M to carry intestinal diabetes procedure to the FDA

Endogenex has raised $50 million in venture capital financing to complete the development of its minimally invasive procedure ...
Healio

Duodenal mucosal renewal plus semaglutide may lower HbA1c long term without insulin use

Please provide your email address to receive an email when new articles are posted on . Twelve of 14 adults who underwent ReCET and received semaglutide maintained an HbA1c of less than 7.5% without ...
The Manila Times

Endogenex Announces Publication of REGENT-1 Clinical Study Results in Diabetes, Obesity and Metabolism

Peer-Reviewed Data Show Durable HbA1c Reduction, Significant Weight Loss, and a Favorable Safety Profile Through 48 Weeks Following a Single Endoscopic Procedure for Type 2 Diabetes ...
Healio

Use both HbA1c, CGM metrics for optimal diabetes management

Please provide your email address to receive an email when new articles are posted on . Studies have found discordance between HbA1c and glucose management indicator. HbA1c remains the standard for ...